Improving HIV pre-exposure prophylaxis (PrEP) adherence and retention in care: Process evaluation and recommendation development from a nationally implemented PrEP programme
PLOS ONE · 09.10.2023 · 18 (10) · e0292289
DOI: 10.1371/journal.pone.0292289 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 09.10.2023. Verfasst von Jennifer MacDonald und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre for Health (ReaCH), Glasgow Caledonian University, Glasgow, Scotland, United Kingdom. Hauptthemen laut MEDLINE: HIV Infections, Pre-Exposure Prophylaxis, Retention in Care, Anti-HIV Agents. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Chief Scientist Office, Scottish Government Health and Social Care Directorate.
Abstract (Originalsprache)
Introduction
HIV pre-exposure prophylaxis (PrEP), in which people take HIV medication to prevent HIV acquisition, underpins global HIV transmission elimination strategies. Effective prevention needs people to adhere to PrEP and remain in care during periods of risk, but this is difficult to achieve. We undertook a process evaluation of Scotland’s PrEP programme to explore barriers and facilitators to PrEP adherence and retention in care and to systematically develop evidence-based, theoretically-informed recommendations to address them.
Methods
We conducted semi-structured interviews and focus groups (09/2018-07/2019) with patients who identified as gay or bisexual men and were either using PrEP, had declined the offer of PrEP, had stopped PrEP, or had been assessed as ineligible for PrEP (n = 39 of whom n = 5 (13%) identified as trans, median age 31 years and interquartile range 14 years), healthcare professionals involved in PrEP provision (n = 54 including specialist sexual health doctors and nurses of various grades, PrEP prescribing general practitioners, health promotion officers, midwifes, and a PrEP clinical secretary), and clients (n = 9) and staff (n = 15) of non-governmental organisations with an HIV prevention remit across Scotland. We used thematic analysis to map key barriers and facilitators to priority areas that could enhance adherence and retention in care. We used implementation science analytic tools (Theoretical Domains Framework, Intervention Functions, Behaviour Change Technique Taxonomy, APEASE criteria) and expert opinion to systematically generate recommendations.
Results
Barriers included perceived complexity of on-demand dosing, tendency for users to stop PrEP before seeking professional support, troublesome side-effects, limited flexibility in the settings/timings/nature of review appointments, PrEP-related stigma and emerging stigmas around not using PrEP. Facilitators included flexible appointment scheduling, reminders, and processes to follow up non-attenders. Examples of the 25 recommendations include: emphasising benefits of PrEP reviews and providing appointments flexibly within individualised PrEP care; using clinic systems to remind/recall PrEP users; supporting PrEP conversations among sexual partners; clear on-demand dosing guidance; encouraging good PrEP citizenship; detailed discussion on managing side-effects and care/coping planning activities.
Conclusions
PrEP adherence and retention in care is challenging, reducing the effectiveness of PrEP at individual and population levels. We identify and provide solutions to where and how collaborative interventions across public health, clinical, and community practice could address these challenges.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Research Centre for Health (ReaCH), Glasgow Caledonian University, Glasgow, Scotland, United Kingdom.
- Sandyford Sexual Health Services, NHS Greater Glasgow and Clyde, Glasgow, Scotland, United Kingdom.
- School of Psychological Sciences and Health, University of Strathclyde, Glasgow, Scotland, United Kingdom.
- College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, United Kingdom.
- Centre for Biomedicine, Self & Society, University of Edinburgh, Edinburgh, Scotland, United Kingdom.
- Chalmers Sexual Health Centre, NHS Lothian, Edinburgh, Scotland, United Kingdom.
ORCID-Profile: Claudia S Estcourt
Förderung
- Medical Research Council
- Chief Scientist Office, Scottish Government Health and Social Care Directorate
Zitieren
APA
MacDonald, J., Estcourt, C. S., Flowers, P., Nandwani, R., Frankis, J., Young, I., Clutterbuck, D., Dalrymple, J., McDaid, L., Steedman, N., & Saunders, J. (2023). Improving HIV pre-exposure prophylaxis (PrEP) adherence and retention in care: Process evaluation and recommendation development from a nationally implemented PrEP programme. PLOS ONE, 18(10), e0292289. https://doi.org/10.1371/journal.pone.0292289
Vancouver
MacDonald J, Estcourt CS, Flowers P, Nandwani R, Frankis J, Young I, et al. Improving HIV pre-exposure prophylaxis (PrEP) adherence and retention in care: Process evaluation and recommendation development from a nationally implemented PrEP programme. PLOS ONE. 2023;18(10):e0292289. doi:10.1371/journal.pone.0292289
BibTeX
@article{MacDonald2023,
author = {MacDonald, Jennifer and Estcourt, Claudia S and Flowers, Paul and Nandwani, Rak and Frankis, Jamie and Young, Ingrid and Clutterbuck, Dan and Dalrymple, Jenny and McDaid, Lisa and Steedman, Nicola and Saunders, John},
title = {Improving HIV pre-exposure prophylaxis (PrEP) adherence and retention in care: Process evaluation and recommendation development from a nationally implemented PrEP programme},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {10},
pages = {e0292289},
doi = {10.1371/journal.pone.0292289}
}
EUVIMED